Analysis of biofluids for gamma-hydroxybutyrate (GHB) and gamma-butyrolactone (GBL) by headspace GC-FID and GC-MS

被引:66
作者
LeBeau, MA [1 ]
Montgomery, MA [1 ]
Miller, ML [1 ]
Burmeister, SG [1 ]
机构
[1] Fed Bur Invest, FBI Lab, Chem Unit, Washington, DC 20535 USA
关键词
D O I
10.1093/jat/24.6.421
中图分类号
O65 [分析化学];
学科分类号
070302 ; 081704 ;
摘要
The past few years have seen a dramatic increase in the abuse of gamma-hydroxybutyrate (GHB) and gamma-butyrolactone (GBL) in the United States. The abuse stems primarily from their euphoric and sedative properties, but these substances are also misused by bodybuilders as steroid alternatives. Recently there has been an alarming increase in the use of GHB and GBL in crimes of drug-facilitated sexual assault. A rapid and sensitive procedure was developed for the analysis of biofluids containing GHB and GBL. Two separate aliquots of a biological specimen were spiked with an alpha-methylene-gamma-butyrolactone internal standard solution. One of the aliquots was treated with concentrated sulfuric acid for cyclization of GHB to GBL and the other remained untreated. Both aliquots were extracted with methylene chloride and concentrated. Extracts were screened using automated headspace gas chromatography-flame-ionization detection (GC-FID). Qualitative findings were quantitated and confirmed in a manner similar to the GC-FID procedure with some modifications. A calibrated solution of GHB-d6 (or GBL-d6, when warranted) was added to the aliquots at a concentration approximating the level determined by the GC-FID screen. The extraction was as described with conversion of GHB to GBL, but analysis was by full-scan gas chromatography-mass spectrometry (EI). Quantitation was performed by comparison of the area of the molecular ion of the parent drug (m/z 86) to that of the calibrated deuterated analogue (m/z 92). This analytical procedure allows for the rapid detection of GHB and GBL in biofluids. Its sensitivity has proven useful for the toxicological investigation of cases of drug-facilitated sexual assault.
引用
收藏
页码:421 / 428
页数:8
相关论文
共 25 条
[1]  
*AM PROS RES I, 1999, PROS ROH GHB REL SEX, P7
[2]  
BASELT RC, 2000, DISPOSITION TOXIC DR, P386
[3]   GAMMA-HYDROXYBUTYRATE, A NORMAL BRAIN METABOLITE [J].
BESSMAN, SP ;
FISHBEIN, WN .
NATURE, 1963, 200 (491) :1207-&
[4]   Chemical submission: GHB, benzodiazepines, and other knock out drops [J].
Bismuth, C ;
Dally, S ;
Borron, SW .
JOURNAL OF TOXICOLOGY-CLINICAL TOXICOLOGY, 1997, 35 (06) :595-598
[5]  
*CDC, 1991, JAMA-J AM MED ASSOC, V265, P447
[6]   METABOLISM OF GAMMA-HYDROXY-[1-C-14] BUTYRATE BY RAT-BRAIN - RELATIONSHIP TO KREBS CYCLE AND METABOLIC COMPARTMENTATION OF AMINO-ACIDS [J].
DOHERTY, JD ;
ROTH, RH .
JOURNAL OF NEUROCHEMISTRY, 1978, 30 (06) :1305-1309
[7]  
DOHERTY JD, 1978, J PHARMACOL EXP THER, V207, P130
[8]   Prevalence of drugs used in cases of alleged sexual assault [J].
ElSohly, MA ;
Salamone, SJ .
JOURNAL OF ANALYTICAL TOXICOLOGY, 1999, 23 (03) :141-146
[9]   THERAPEUTIC GAMMA-HYDROXYBUTYRIC ACID MONITORING IN PLASMA AND URINE BY GAS-CHROMATOGRAPHY MASS-SPECTROMETRY [J].
FERRARA, SD ;
TEDESCHI, L ;
FRISON, G ;
CASTAGNA, F ;
GALLIMBERTI, L ;
GIORGETTI, R ;
GESSA, GL ;
PALATINI, P .
JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS, 1993, 11 (06) :483-487
[10]  
FRISON G, P 1998 JOINT SOFT TI, P394